INTRODUCTION
Clinical recognition of systemic lupus erythematosus (SLE) in individual patients is often complicated by the wide spectrum of clinical manifestations which may simulate other disease entities. Conversely, the systemic features of SLE may be masked, at least initially, when clinical signs are restricted to a single organ system. To establish a uniform means to identify and classify patients with SLE, the American Rheumatology Association (ARA) published diagnostic criteria in 1971 which included 14 criteria, eight of which were clinical and six were laboratory [ 1] . The presence of four or more criteria in an individual patient was construed to be compatible with the diagnosis of SLE.
Despite the usefulness of the criteria proposed by the ARA, occasional patients with SLE have been reported in whom these criteria were not fulfilled at the time of initial clinical presentation [2, 3] . Since SLE exhibits a variable natural course and the criteria proposed by the ARA were derived from patients attending rheumatology clinics, it is not surprising that exceptions to the classification occur.
Although previous reports have stated that lupus nephropathy may occur as the sole presenting sign of SLE in three to six percent of cases [2, 3] , documentation has not been provided to establish the existence of lupus nephropathy in the absence of non-renal manifestations at onset of disease. Recognition of this possible clinical variant of SLE has important clinical implications since treatment with glucocorti-353 coids and/ or cytotoxic drugs may alter the renal histopathology and clinical course of lupus nephropathy [4] .
In the present report, we describe four patients with SLE in whom the initial clinical manifestation was restricted to signs of In June 1977, while asymptomatic, the DNA-bc rose to 34 percent and C3 fell to 26 mg/dl. Urinary protein excretion was 300 mg/day. With six weeks, a macular erythematous rash appeared on the lower extremities and was shown to be a leukocytoclastic angiitis by biopsy. Urinary protein excretion rose to 1.7 gm/day and the serum creatinine was 1.1 mg/dl. A fourth renal biopsy showed an increase in proliferation of intraglomerular cells and return of subendothelial deposits. Azathioprine 100 mg/day was reinstituted and the dose of prednisone was raised to 40 mg/day. The rash on the lower extremities resolved within one week and urinary protein excretion returned to normal levels within four weeks. Concurrent with clinical improvement, the C3 level rose to 90 mg/ dl and DNA-bc fell to below 15 percent. The patient remained clinically stable during the ensuing 36 months on azathioprine 100 mg/day and prednisone 10 mg/day.
Comment
The diagnosis of SLE in this patient was based on the renal histopathology, the elevated titers of ANF, and reduced C3 level. Subsequently, the patient developed a cutaneous vasculitis and elevated level of DNA antibodies.
Case 2 K.A., a five-year-old girl, was transferred from a community hospital for evaluation of proteinuria and generalized edema of two months' duration. During the two weeks prior to admission, she had had occasional temperatures of 101 'F. There was no antecedent history of throat or skin infection. In addition, there was no history of drug ingestion, rash, arthritis, or mucosal lesions. Physical examination was notable for a temperature of 102.40 F., ascites, and peripheral edema. Laboratory tests showed the following: Hg 8.0 gm/dl, WBC 10,400/ml, platelets 550,000, urinalysis 4+ protein, many RBC and RBC casts, serum albumin 1.3 gm/dl, serum creatinine of 2.6 mg/dl, ANF titer 1:512, DNA-bc 78 percent, C3 22 mg/dl, C4 20 mg/ d 1 (normal 21-50 mg/ dl). A percutaneous renal biopsy revealed a severe proliferative glomerulonephritis with focal necrosis and numerous cellular crescents. Electronmicroscopy showed massive subendothelial deposits and focal mesangial and intramembranous deposits. Several deposits had a fingerprint pattern. On immunofluorescent staining, there was a marked deposition of IgG, IgM, IgA, C3, C4, and fibrin in a granular pattern. Over the next five days the patient became oliguric, the serum creatinine level rose further, and peritoneal dialysis was instituted.
Therapy was begun with cyclophosphamide, 25 mg/day and glucocorticoids were administered on alternate days as 40 mg of prednisone orally and 600 mg of methylprednisolone intravenously for a 12-day period. On the ninth day of therapy, a diuresis occurred. Serum creatinine levels which had risen to 3.2 mg/dl fell to 1.2 mg/ dl and peritoneal dialysis was discontinued. She was subsequently maintained on cyclophosphamide 25 mg/day and prednisone 40 mg/day. Over the next nine months, renal function continued to improve and prednisone was tapered to 5 mg/day. She continues to be free of edema without salt restriction or diuretics, and she has no signs or symptoms of SLE. Current laboratory studies include: serum creatinine 0.5 mg/dl, 24-hour urinary protein excretion 3.0 grams, ANF titer 1:4, DNA-bc 5 percent, C3 93 mg/ dl, C4 46 mg/ dl.
The diagnosis of SLE is based on the characteristic renal histopathology, elevated titers of ANF and DNA-bc, and reduced C3 levels. Fever at the time of her initial presentation may have represented another manifestation of SLE. The patient was discharged on diuretic therapy alone. The following year she became pregnant. The delivery was complicated by hypertension and increased edema. Laboratory studies included: ANF 1: 128, DNA-bc 13 percent. One month post partum, she was hospitalized because of fever, persistent hypertension, and signs of congestive heart failure. Physical examination revealed S3 and S4 gallops and bilateral dullness to percussion with absent breath sounds at the lung bases. Laboratory tests included: urinalysis 4+ protein, normal urinary sediment, urinary protein excretion 9.3 gm/day, serum creatinine 0.7 mg/dl, creatinine clearance 130 ml/min, ANF 1:128, LE preparation +, C3 51 mg/dl, C4 11 mg/dl. A 99 M Tc sodium pertechnetate first pass dynamic heart scan was performed and showed an ejection fraction of 36 percent (normal value > 55 percent). During the first week of hospitalization, the patient continued to have temperatures to 103.6°F. The patient was placed on prednisone, 90 mg/ day, which resulted in rapid defervescence. She was discharged on prednisone, digitalis, and furosemide. She was readmitted several months later with fever and a right lower lobe infiltrate on chest roentgenogram. Laboratory studies showed: serum creatinine 0.9 mg/dl, ANF 1:64, DNA-bc 4 percent, C3 98 mg/dl, C4 33 mg/dl. She was treated with antibiotics, recovered rapidly, and was discharged on the sixth hospital day. Since that time her clinical condition has remained stable. Comment The elevated DNA-bc level and mesangial deposits, in association with epimembranous deposits, by renal biopsy, strongly suggested the possibility of SLE in 1976 when this patient was first evaluated for nephrotic syndrome. The diagnosis of SLE was established subsequently by the positive LE preparation. The fever and cardiomyopathy which occurred post partum probably represent systemic manifestations of SLE. DISCUSSION The four patients described in this report initially sought medical care because of generalized edema due to nephrotic syndrome. Except for patient 2, in whom fever occurred initially, there were no signs or symptoms suggestive of SLE at the time of initial presentation. During follow-up, however, each of the other three patients ultimately developed clinical findings frequently associated with the systemic manifestations of SLE: Patient 1 had a rash due to a leukocytoclastic angiitis, patient 3 developed a recurrent fever of unknown etiology, and patient 4 had fever and myocardopathy. It is noteworthy that the hallmark findings of SLE, such as facial erythemia, Raynaud's phenomena, alopecia, photosensitivity, and arthritis, did not occur in any of these four patients.
The diagnosis of SLE in these cases was established on the basis of serological studies and renal histopathological findings. In cases 1-3, the finding of a proliferative glomerulonephritis with electron-dense deposits in subendothelial, subepithelial, and mesangial loci was considered to be highly suggestive of lupus nephropathy [6, 7] . The combination of clinical features and renal histopathology were not compatible with other entities in which subendothelial deposits are also found, such as postinfectious glomerulonephritis [8] , mesangiocapillary glomerulonephritis [9] , and Henoch-Scholein purpura [10] . The renal biopsy findings in case 4 were also suggestive of lupus nephropathy because of the association of mesangial and epimembranous electron-dense deposits. Mesangial deposits have not been described, characteristically, in idiopathic membranous nephropathy [6] , but are commonly found in patients with membranous lupus nephropathy [7] .
Serological studies were used to confirm the diagnosis of SLE. In each case, an antinuclear factor was found and either identified as an anti-DNA antibody or associated with a positive LE preparation. Patient 1 had an elevated ANF titer and reduced C3 on initial evaluation, and subsequently an elevated DNA-bc. Patient 2 had elevated ANF titer, increased DNA-bc, and reduced C3. Patient 3 had elevated ANF titer, positive LE preparation, and reduced C3. Patient 4 had elevated DNA-bc initially, and later a positive LE preparation, elevated ANF titer, and reduced C3. A DNA-bc level greater than 20 percent was considered highly specific for SLE. Adler and associates, working in our laboratory, previously reported that levels of DNA-bc did not exceed 20 percent in normal individuals or patients with rheumatoid arthritis or rheumatoid variants [5] . Moreover, except for the report by Pincus and associates [ 11] , other groups have also reported that DNA-bc greater than 20 percent is highly discriminatory for SLE in untreated patients [12, 13, 14, 15, 16, 17] .
Several reports of large series of patients have stated that lupus nephropathy may represent the initial clinical manifestation of SLE in three to six percent of cases [2, 3] . This type of clinical presentation of SLE, however, has not been documented since data were not included that either demonstrated the diagnosis of SLE or the type of renal disease at onset of illness. Lupus nephropathy as the sole presenting manifestation of SLE was also suggested by two recent reports. Libit and associates described three children, ages 10 to 14 years, with epimembranous nephropathy who developed clinical and serological evidence of SLE which included the appearance of rash and multisystem disease one and a half to three and a half years after the first evidence of renal disease [ 18] . In contrast to the cases in the present report, serological studies for SLE were negative at the time of the initial evaluation. Two similar cases were reported by Kallen and associates [19] , in which the nephrotic syndrome, due to typical epimembranous nephropathy, developed in the absence of serological evidence of SLE. One and three years later, respectively, both children developed systemic manifestations and serological evidence of SLE. Re-evaluation, by renal biopsy, demonstrated a proliferative glomerulonephritis with electron-dense deposits in subendothelial and mesangial loci, in addition to epimembranous deposits in both cases. Although there was no direct evidence that the initial glomerulonephropathy in these previously reported cases was caused by SLE, the authors suggested a causal relationship since both membranous nephropathy and SLE, as separate disease entities, are relatively uncommon in children.
The present report documents the occurrence of lupus nephropathy as the sole initial manifestation of SLE. It becomes evident, therefore, that under certain circumstances, the diagnostic criteria established by the ARA may not be sufficiently inclusive for all cases of SLE. These findings emphasize the importance of considering the possibility of SLE even in patients with apparent primary renal disease. Observations made in the present series of patients suggest that important clues to the eventual diagnosis of SLE may be provided by careful assessment of the pattern of glomerular ultrastructural changes and that confirming evidence can be obtained by appropriate serological studies.
